The Piece Everyone Forgets: Your Fibroblasts Need Raw Materials This is genuinely under-discussed and might explain why some people see results and others don't, even with identical products and protocols
Artificial Cells, Nanomedicine, and Biotechnology, 48 (1), 11531158
Patients with a history of diabetic retinopathy should be monitored for progression of diabetic retinopathy during treatment
Biopolymer-based nanotechnology approaches to deliver bioactive compounds for food applications: A perspective on the past, present, and future
Pharm Biol (2020) 58:11319
*Correspondence: Xi Cheng, [email protected] Niu, [email protected] These authors have contributed equally to this work and share first authorship This article was submitted to Dementia and Neurodegenerative Diseases, a section of the journal Frontiers in Neurology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers